1. Landscape of genomic alterations identified by WES in biopsies of patients with advanced PDAC. Co-mutation plot displaying integrated genomic data for 71 samples displayed as columns, including somatic mutations, high-level amplifications and homozygous del...
Landscape of genomic alterations identified by WES in biopsies of patients with advanced PDAC. Co-mutation plot displaying integrated genomic data for 71 samples displayed as columns, including somatic mutations, high-level amplifications and homozygous deletions, and germline mutations for selected genes. For each sample, the site of biopsy, the ABSOLUTE neoplastic cellularity (purity) from WES data, and the neoplastic cellularity as assessed by histologic evaluation are shown as tracks at the top. Significantly mutated genes with q value ≤ 0.1 that were identified by exome sequencing are listed at the top (black) vertically in order of decreasing significance. Genes from recurrently altered functional classes are also shown, including tumor suppressor genes (yellow), oncogenes (red), DDR genes (green), and chromatin modification genes (blue). H&E, hematoxylin and eosin; LN, lymph node; Indel, insertion/deletion.
Andrew J. Aguirre et al. Cancer Discov 2018;8:
©2018 by American Association for Cancer Research